Frank M. Fischer - 31 Mar 2024 Form 4 Insider Report for NEVRO CORP

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 31 Mar 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Apr 2024, 19:04:41 UTC
Prior SEC filing: 03 Jan 2024
Next SEC filing: 11 Jun 2024
Source filing: View source filing
Reporting owner signature: /s/ Kashif Rashid, as Attorney-in-Fact for Frank M. Fischer

Key filing fact

Frank M. Fischer filed Form 4 for NEVRO CORP on 02 Apr 2024.

Key facts

This page summarizes Frank M. Fischer's Form 4 filing for NEVRO CORP.
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 02 Apr 2024, 19:04.

Change

Previous filing in this sequence was filed on 03 Jan 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NVRO transaction

Common Stock

Award

Transaction value: $0
Shares: +1,159
Change %: +2.1%
Price: $0.000000
Shares after: 57,500
Date: 31 Mar 2024
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Fully vested restricted stock. The restricted stock represent quarterly retainer fees that the Reporting Person elected to receive in the form of shares of common stock in lieu of cash.

Footnote F2

Includes 6,754 restricted stock units.